Strength
75 mg/1
Manufacturer
Sumitomo Pharma America, Inc.NDC
73336007530
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
VIBEGRONApproval Type
New Drug (NDA)
FDA Application
NDA213006On Market Since
12/29/2020
Pharmacological Classes
Adrenergic beta3-Agonists
beta3-Adrenergic Agonist
Related Drugs
Same classification
MYRBETRIQ ER 8 MG/ML SUSP
Brand
00469502099•Astellas Pharma US, Inc.
$2.2097
per ML
MYRBETRIQ ER 50 MG TABLET
Brand
00469260230•Astellas Pharma US, Inc.
$14.6948
per EA
MYRBETRIQ ER 50 MG TABLET
Brand
00469260290•Astellas Pharma US, Inc.
$14.6948
per EA
MYRBETRIQ ER 25 MG TABLET
Brand
00469260130•Astellas Pharma US, Inc.
$14.6977
per EA
MYRBETRIQ ER 25 MG TABLET
Brand
00469260190•Astellas Pharma US, Inc.
$14.6977
per EA